The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
暂无分享,去创建一个
[1] K. Nazaryan,et al. Rat brain glycolysis regulation by estradiol-17β , 1992 .
[2] B. Sherwin,et al. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review , 2008, Frontiers in Neuroendocrinology.
[3] S. Resnick,et al. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition , 2000, Neurobiology of Aging.
[4] P. M. Wise,et al. Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models , 2006, Neuroscience.
[5] F. Pasquier,et al. A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.
[6] V. Procaccio,et al. Mitochondrial Effects of Estrogen Are Mediated by Estrogen Receptor α in Brain Endothelial Cells , 2008, Journal of Pharmacology and Experimental Therapeutics.
[7] Meharvan Singh. Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex , 2007, Endocrine.
[8] R. Brinton. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. , 2001, Learning & memory.
[9] J. Simpkins,et al. Estrogens and progesterone as neuroprotectants: what animal models teach us. , 2008, Frontiers in bioscience : a journal and virtual library.
[10] F. LaFerla. Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.
[11] L. Garcia-Segura,et al. Estradiol, insulin-like growth factor-I and brain aging , 2007, Psychoneuroendocrinology.
[12] V. Procaccio,et al. Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels , 2005, Molecular Pharmacology.
[13] S. Resnick,et al. Hormone therapy and risk of Alzheimer disease: a critical time. , 2002, JAMA.
[14] Roberta Diaz Brinton,et al. Estrogen Receptor Protein Interaction with Phosphatidylinositol 3-Kinase Leads to Activation of Phosphorylated Akt and Extracellular Signal-Regulated Kinase 1/2 in the Same Population of Cortical Neurons: A Unified Mechanism of Estrogen Action , 2006, The Journal of Neuroscience.
[15] R. Brinton. Investigative Models for Determining Hormone Therapy‐Induced Outcomes in Brain: Evidence in Support of a Healthy Cell Bias of Estrogen Action , 2005, Annals of the New York Academy of Sciences.
[16] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Brinton,et al. 17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection , 2005, Neuroscience.
[18] Richard J. Caselli,et al. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions , 2008, NeuroImage.
[19] J. Morrison,et al. Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women , 2006, The Journal of Neuroscience.
[20] R. Brinton,et al. 17β-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: A potential initiation mechanism for estrogen neurotrophism , 2005, Neuroscience.
[21] H. Fillit,et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer's type , 1986, Psychoneuroendocrinology.
[22] C. Bondy,et al. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Brenda L Plassman,et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.
[24] K. Yaffe. Hormone therapy and the brain: déjà vu all over again? , 2003, JAMA.
[25] P. Landfield. ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.
[26] R. Irwin,et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function , 2006, BMC Neuroscience.
[27] R. Brinton,et al. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. , 2006, Endocrinology.
[28] Anthony Gamst,et al. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .
[29] S. Resnick,et al. Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Neuropsychological Performance , 1998, Hormones and Behavior.
[30] B. McEwen,et al. Nuclear and extranuclear estrogen binding sites in the rat forebrain and autonomic medullary areas. , 2008, Endocrinology.
[31] D. Wallace. Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. , 2007, Annual review of biochemistry.
[32] J. Morrison,et al. Frontiers proposal. National Institute on Aging “bench to bedside: estrogen as a case study” , 2009, AGE.
[33] E. Wang,et al. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] B L Miller,et al. Estrogen for Alzheimer’s disease in women , 2000, Neurology.
[35] Z. Khachaturian. Introduction and Overview , 1989, Annals of the New York Academy of Sciences.
[36] P. Landfield,et al. Ca2+ regulation and gene expression in normal brain aging , 2004, Trends in Neurosciences.
[37] R. Brinton,et al. The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective , 2000, Neurobiology of Aging.
[38] J. Gambini,et al. Mitochondrial oxidant generation is involved in determining why females live longer than males. , 2007, Frontiers in bioscience : a journal and virtual library.
[39] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[40] R. Brinton,et al. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. , 2002, Endocrinology.
[41] S. Miyamoto,et al. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II , 2008, Cell Death and Differentiation.
[42] P. Moreira,et al. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes , 2007, Journal of the Neurological Sciences.
[43] C. Cotman,et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. , 2000, JAMA.
[44] R. Martins,et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease , 2006, Molecular Psychiatry.
[45] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[46] H. Chui,et al. Incidence of dementia in long-term hormone users. , 2007, American journal of epidemiology.
[47] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[48] V. Procaccio,et al. Estrogen and mitochondria: a new paradigm for vascular protection? , 2006, Molecular interventions.
[49] G. Small,et al. Estrogen use and brain metabolic change in postmenopausal women , 2004, Neurobiology of Aging.
[50] Gregory J. Brewer,et al. Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons , 2006, Neurobiology of Aging.
[51] E. Kandel,et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.
[52] T. Gómez-Isla,et al. Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.
[53] Rachel L. Mistur,et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.
[54] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[55] A. Maggi,et al. Estrogen Induction of Cytochrome c Oxidase Subunit III in Rat Hippocampus , 1992, Journal of neurochemistry.
[56] J. Barrett,et al. Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats , 2007, The Journal of Neuroscience.
[57] F. Sohrabji. Estrogen: A Neuroprotective or Proinflammatory Hormone? Emerging Evidence from Reproductive Aging Models , 2005, Annals of the New York Academy of Sciences.
[58] D. Geschwind,et al. A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging , 2008, The Journal of Neuroscience.
[59] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[60] R. Brinton,et al. Mitochondria as therapeutic targets of estrogen action in the central nervous system. , 2004, Current drug targets. CNS and neurological disorders.
[61] J. Blass,et al. Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.
[62] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[63] K. Yaffe,et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.
[64] T. Foster,et al. Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment , 2003, The Journal of Neuroscience.
[66] E. Levin. highlighted topics Genome and Hormones: Gender Differences in Physiology Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors , 2001 .
[67] E. Cadenas. Mitochondrial free radical production and cell signaling. , 2004, Molecular aspects of medicine.
[68] R. Irwin,et al. Estradiol In Vivo Regulation of Brain Mitochondrial Proteome , 2007, The Journal of Neuroscience.
[69] Roberta Diaz Brinton,et al. Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Simpkins,et al. Mitochondrial mechanisms of estrogen neuroprotection , 2008, Brain Research Reviews.
[71] Leslie Carol Botha. Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women , 2003 .
[72] J. Simpkins,et al. Estrogen actions on mitochondria—Physiological and pathological implications , 2008, Molecular and Cellular Endocrinology.
[73] Roberta Diaz Brinton,et al. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway , 2002, Brain Research.
[74] A. Pupi,et al. PET is better than perfusion SPECT for early diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.